Jun
2026
Shanghai New International Expo Center
Visit us
stand E1.1A14, Pharma Excipients
Zone

Octapharma

About Us

Company highlights • A global healthcare company headquartered in Lachen, Switzerland • Family-owned since being established in 1983 • The largest independent plasma fractionator in the world • 5 state-of-the-art manufacturing sites • More than 190 own plasma donation centers across Europe and the US which maximizes long term security of supply For research and further manufacturing use • EP/USP/GMP • Pharmaceutical grade • Pathogen inactivated • Regulatory, technical, and quality support • Our focus segments include gene and cell therapy, vaccines, in vitro fertilization, drug formulation, and drug carriers

  • Country/Region:
    Switzerland
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    5000+
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Excipients Manufacturer
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E1.1A14, Pharma Excipients

Products Featured at CPHI & PMEC China 2026

  • Human Serum Albumin

    Product Human Serum Albumin

    Human Serum Albumin for research and further manufacturing use.

    Human Serum Albumin (HSA) is the most common plasma protein. The molecule is very flexible and easily changes shape when exposed to altered environmental conditions and upon binding to ligands.

    HSA is widely used as an excipi...
  • Human Normal Immunoglobulins

    Product Human Normal Immunoglobulins

    Human Normal Immunoglobulin for research and further manufacturing use.

    Human Normal Immunoglobulin preparations are liquid solutions primarily composed of Immunoglobulin G (IgG), a Y-shaped antibody molecule. IgG antibodies are the most common in blood plasma, making up about 80% of all antib...
  • Human Fibrinogen

    Product Human Fibrinogen

    Human Fibrinogen for research and further manufacturing use.

    Fibrinogen (Factor I) is a large, complex glycoprotein that can be converted to fibrin, one of the key components to promote wound healing.
    Fibrinogen has various applications in pharmaceutical and biotechnological...
  • Human Antithrombin III

    Product Human Antithrombin III

    Human Antithrombin III for research and further manufacturing use

    Antithrombin III is a normal component of human plasma and an important blood coagulation inhibitor.

    Antithrombin III is a small glycoprotein that inactivates several enzymes due to its anticoagulant properties, with its ...
  • Virus Inactivated Plasma

    Product Virus Inactivated Plasma

    Virus Inactivated Plasma for research and further manufacturing use

    Human Plasma makes up approximately 55% of our blood and contains over 60different proteins e.g. albumin, coagulation factors and inhibitors. Human Plasma cannot be produced genetically or synthetically.

    Virus Inactivat...

Octapharma AG Resources (1)